Winzest Tablet contains Levo-carnitine 500 mg, a naturally occurring amino acid derivative essential for the transport of long-chain fatty acids into the mitochondria for beta-oxidation and energy production. It is primarily indicated for the management of carnitine deficiency, which may arise due to genetic disorders, chronic illnesses, or certain medications. Levo-carnitine supplementation helps improve cellular energy metabolism, thereby enhancing muscle function and reducing symptoms of fatigue and muscle weakness. Additionally, Winzest Tablet is utilized as an adjunct therapy in conditions such as chronic kidney disease, peripheral arterial disease, and cardiac disorders where carnitine levels are compromised. The drug exhibits antioxidant properties and may aid in the reduction of oxidative stress. Dosage and duration of therapy should be individualized based on clinical condition and patient response, with monitoring for efficacy and tolerability. Common adverse effects are generally mild and may include gastrointestinal disturbances such as nausea, vomiting, and abdominal cramps. Winzest Tablet should be used with caution in patients with hypothyroidism or seizure disorders. It is contraindicated in individuals with known hypersensitivity to Levo-carnitine. Consultation with a healthcare professional is recommended before initiating therapy to ensure appropriate use and to avoid potential drug interactions.